Bupropion for Smoking Cessation in African American Light Smokers: A Randomized Controlled Trial
Authors:
- Lisa Sanderson CoxLCLisa Sanderson Cox
- Nicole L. NollenNNNicole L. Nollen
- Matthew S. MayoMMMatthew S. Mayo
- Won S. ChoiWCWon S. Choi
- Babalola FaseruBFBabalola Faseru
- Neal L. BenowitzNBNeal L. Benowitz
- Rachel F. TyndaleRTRachel F. Tyndale
- Kolawole S. OkuyemiKOKolawole S. Okuyemi
- Jasjit S. AhluwaliaJAJasjit S. Ahluwalia
Open Access
- 25 January 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 104 (4) , 290-298
Abstract
Previous research demonstrated the efficacy of sustained release bupropion (bupropion SR) for smoking cessation in whites as well as moderate to heavy (≥10 cigarettes per day [CPD]) African American smokers. We evaluated whether bupropion SR was effective for smoking cessation among African American light smokers (≤10 CPD). A randomized, double-blind placebo-controlled trial was conducted from December 27, 2007, to May 13, 2010. All participants were African American light smokers (≤10 CPD), aged 18 years or older. Participants were randomly assigned to receive 300 mg bupropion SR (150 mg once daily for 3 days and then 150 mg twice daily) (n = 270 participants) or placebo (n = 270 participants) for 7 weeks, and up to six sessions of health education counseling. Serum cotinine was measured at baseline (week 0). The primary outcome was salivary cotinine–verified 7-day point prevalence smoking abstinence at week 26; a cut point of 15 ng/mL differentiated smokers from nonsmokers. Salivary cotinine–verified smoking abstinence at end of medication treatment at week 7 was also examined. Odds ratios (OR) for smoking abstinence and 95% confidence intervals (CIs) were calculated using logistic regression models. All statistical tests were two-sided. Participants at baseline visit (week 0) smoked an average of 8.0 CPD and had a mean serum cotinine level of 275.8 ng/mL (SD = 155.8 ng/mL); most used menthol cigarettes (83.7%) and smoked within 30 minutes of waking (72.2%). After imputing those lost to follow-up as smokers, no statistically significant difference in long-term smoking abstinence rates at week 26 was observed between bupropion SR and placebo groups (13.3% vs 10.0%, OR = 1.39, 95% CI = 0.82 to 2.35, P = .23). Cotinine-verified smoking abstinence rate at end of medication week 7 was higher in the bupropion SR vs placebo group (23.7% vs 9.6%, OR = 2.92, 95% CI = 1.78 to 4.77, P < .001). Bupropion SR was effective in promoting smoking cessation during the medication phase of treatment but showed no effect on long-term smoking cessation among African American light smokers. More research is needed to identify strategies for sustaining abstinence among African American light smokers.Keywords
This publication has 41 references indexed in Scilit:
- Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological dataTrials, 2011
- Utility and Relationships of Biomarkers of Smoking in African-American Light SmokersCancer Epidemiology, Biomarkers & Prevention, 2009
- Comparing smoking treatment programs for lighter smokers with and without a history of heavier smokingJournal of Substance Abuse Treatment, 2009
- Intermittent and light daily smoking across racial/ethnic groups in the United StatesNicotine & Tobacco Research, 2009
- Racial/Ethnic Disparities in the Use of Nicotine Replacement Therapy and Quit Ratios in Lifetime Smokers Ages 25 to 44 YearsCancer Epidemiology, Biomarkers & Prevention, 2008
- Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependenceNicotine & Tobacco Research, 2007
- Randomized Comparison of a Nicotine Inhaler and Bupropion for Smoking Cessation and Relapse PreventionMayo Clinic Proceedings, 2007
- Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smokingBritish Journal of Clinical Pharmacology, 1997
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991
- The CES-D ScaleApplied Psychological Measurement, 1977